4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000050
Chief Scientific Officer gave up 1,756 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-03 | Shares withheld for taxes | −469 | $15.76 | $7,392 | 188,345 | D: show line 1 in the form |
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-03 | Shares withheld for taxes | −151 | $16.93 | $2,556 | 188,194 | D: show line 2 in the form |
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-03 | Shares withheld for taxes | −14 | $17.70 | $248 | 188,180 | D: show line 3 in the form |
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-04 | Shares withheld for taxes | −955 | $15.42 | $14,729 | 187,225 | D: show line 4 in the form |
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-05 | Shares withheld for taxes | −167 | $15.13 | $2,526 | 187,058 | D: show line 5 in the form |
Loading xslF345X05/wk-form4_1725576454.xml…